Related Experiment Video

Updated: May 11, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

Management of crescentic glomerulonephritis: what are the recent advances?

Xiao Li1, Nan Chen

  • 1Department of Nephrology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, PR China.

Contributions to Nephrology
|May 22, 2013
PubMed

Insights

Crescentic glomerulonephritis (GN) is a severe kidney injury. While conventional treatments exist, emerging therapies like targeted antibodies show promise but require further clinical trials for safety and efficacy validation.

Area of Science:

  • Nephrology
  • Immunology
  • Internal Medicine

Background:

  • Crescentic glomerulonephritis (GN) is a severe clinical syndrome indicating significant glomerular injury.
  • Immunologically, crescentic GN is categorized into anti-GBM nephritis, immune complex-mediated GN, and pauci-immune GN.
  • Current treatments include corticosteroids, immunosuppressants, and plasma exchange, with plasmapheresis showing benefit in specific subtypes.

Purpose of the Study:

  • To review the current understanding and treatment landscape of crescentic glomerulonephritis.
  • To highlight emerging therapeutic agents and their potential role in managing crescentic GN.
  • To emphasize the need for rigorous clinical trials to establish the safety and efficacy of novel treatments.

Main Methods:

  • Literature review of crescentic glomerulonephritis (GN) pathogenesis and treatment modalities.
  • Analysis of current therapeutic strategies, including conventional and novel agents.
  • Evaluation of evidence for emerging treatments such as monoclonal antibodies and signal transduction inhibitors.

Main Results:

  • Conventional treatments for crescentic GN involve corticosteroids, immunosuppressants, and plasma exchange.
  • Plasmapheresis is effective for Goodpasture's syndrome and severe pauci-immune GN.
  • New agents targeting T cells, B cells, cytokines (e.g., anti-CD20, TNF-α inhibitors), and signal transduction pathways are under investigation.

Conclusions:

  • Emerging therapies offer potential alternatives for crescentic GN management.
  • Most novel treatments are currently based on limited data from experimental models, case reports, or open-label trials.
  • Controlled clinical trials are essential to determine the safety and efficacy of these new therapeutic agents in crescentic GN.

More Related Videos

Isolation of Glomeruli and In Vivo Labeling of Glomerular Cell Surface Proteins09:12

Isolation of Glomeruli and In Vivo Labeling of Glomerular Cell Surface Proteins

Published on: January 18, 2019

Related Concept Videos

Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...